Effect of non-absorbable antibiotic, rifaximin in patients with irritable bowel syndrome: A single-center randomized controlled study

Journal Title: National Journal of Physiology, Pharmacy and Pharmacology - Year 2018, Vol 8, Issue 6

Abstract

Background: Irritable bowel syndrome (IBS), most common functional bowel disease, does not have a definite treatment. Studies revealed the involvement of bacterial overgrowth for its pathology. The aim of this study is to evaluate the effect of a non-absorbable antibiotic. Aims and Objectives: The primary objective of the study is to assess the efficacy of a 14 days course of oral rifaximin at 400 mg thrice daily in patients with IBS without constipation. The secondary objective of this study is to evaluate the safety of a 14 days course of rifaximin at 400 mg thrice daily as compared with placebo in patients with IBS without constipation. Materials and Methods: In this single-center, randomized, placebo-controlled study, we recruited patients, using Rome III criteria in 2 years. Treatment group received rifaximin 400 mg thrice daily for 2 weeks. All patients underwent symptom assessment and safety assessment before inclusion, at the end of the treatment and 1 week after the regimen. Primary endpoint (proportion of patients who achieved adequate relief of IBS symptoms) and Likert scales of symptoms of both groups were compared. Results: Proportion of subject, who achieved adequate relief of IBS symptoms in the rifaximin arm, is more than placebo (68% vs. 39.1%). At the end of 2 weeks therapy, both groups show significant improvement in bloating score (P < 0.002), pain score (P < 0.001), and overall score (P < 0.002) and it continued for 1 more week. There were no significant adverse effects reported. Conclusion: A 2 weeks course of 400 mg rifaximin thrice daily regimen provided a significant improvement in global IBS symptoms.

Authors and Affiliations

Bhagyalekshmi N, Ramesh M, Prathibha V K, Xavier Ignatius J

Keywords

Related Articles

A study of knowledge, attitude, and practice on generic drugs among teaching faculties at a tertiary care teaching hospital in South Gujarat, India

Background: The practice of generic medicines prescribing, dispensing, and substitution in developing countries has been controversial among doctors, particularly due to issues on quality, safety, and efficacy. These con...

Impact of chronic smoking on lipid peroxidation and electrocardiogram in ischemic heart disease patients

Background: Cigarette smoking is one of the prime contributing factors for atherosclerosis. Chronic cigarette smoking causes disturbances in the electrophysiology of heart and may lead to ventricular arrhythmias. Further...

Effect of rosemary on fasting blood glucose, hemoglobin A1c and Vitamin B12 in healthy person and Type 2 diabetic patients taking glucomid or/and metformin

Background: Diabetes mellitus (DM) is risky threats to human health nowadays, and various trials of treatments were announced including chemical and drugs extracted from medicinal plants. Rosemary plants were shown to ha...

Study of body mass index, waist-to-hip ratio, systolic blood pressure-to-height ratio, and diastolic blood pressure-to-height ratio among prehypertensive and normotensive students

Background: Pre-hypertension (HTN) in adolescents and young adults is an important risk factor for developing HTN in future. Increased body mass index (BMI) and physical inactivity may have an adverse effect on blood pre...

Acute effects of yoga on ocular perfusion pressure in adult yoga practitioners

Background: Ocular perfusion pressure (OPP) is an important determinant of ocular blood flow. Reduced OPP could be a risk factor for glaucoma. According to the WHO, glaucoma is the second leading cause of...

Download PDF file
  • EP ID EP490385
  • DOI 10.5455/njppp.2018.8.1246807022018
  • Views 82
  • Downloads 0

How To Cite

Bhagyalekshmi N, Ramesh M, Prathibha V K, Xavier Ignatius J (2018). Effect of non-absorbable antibiotic, rifaximin in patients with irritable bowel syndrome: A single-center randomized controlled study. National Journal of Physiology, Pharmacy and Pharmacology, 8(6), 867-871. https://europub.co.uk/articles/-A-490385